Galapagos NV: business update: http://t.co/6w1jppWE
posted 4 days ago
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
Q-Biologicals, a biotech company focused on providing services in the field of process development and manufacturing of recombinant proteins, viruses and live cells, announces that it has entered into a service framework agreement with Bayer CropScience to produce and purify recombinant proteins for Bayer. Production of two recombinant proteins has already been commissioned.
Q-Biologicals CEO, Annie Van Broekhoven, comments: The signing of this service framework agreement is a strong endorsement of the need of service provider like Q-Biologicals in the Flanders region. This collaboration with Bayer is an important step in fulfilling our ambition to become a key player in the field of production of Biologicals.
Originating from the former Biologicals department of Innogenetics – Fujirebio and incorporating technology acquired from the Protein Service Facility of VIB (Flanders Institute for Biotechnology) and Ghent University, Q-Biologicals is offering services to third parties to help them in speeding up the development and manufacturing of their biological products.
These services are provided in a two-way approach: (1) Process and analytical method development and manufacturing services, including cGMP production, and (2) Consultancy based on our hands-on experience, under the motto “We perform the work for you”.
The principal technological expertise of Q-Biologicals is the production of recombinant proteins derived from microbial as well as eukaryotic systems, purification of recombinant proteins for research purposes and with pharmaceutical grade quality, including formulation development and stress stability studies. Q-Biologicals also has an extensive expertise in the manufacturing of viruses and living cells for vaccine purposes and in-depth knowledge of working under industrial and cGMP quality requirements.
Bayer is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer CropScience, a subgroup of Bayer AG with annual sales of EUR 6.830 billion (2010), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 20,700 and is represented in more than 120 countries.
Source: Q-Biologicals
Tags: collaborations
Bookmark this:
